SK Hynix’s New York chip plans hit snag over US restrictions on China, sources say

The U.S. Commerce Department has not approved SK Hynix’s requested export licenses for American chipmaking equipment to expand its Dalian, China, plant, complicating plans tied to a potential U.S. NAND-fab investment. Two people said Solidigm plans to invest about $45 billion in two plants in Marcy, New York, potentially reaching $100 billion over time; Solidigm says it is exploring locations and has made no decision on a specific course of action. Negotiations continue, with approval dependent on the administration’s national-security and investment priorities.

Analysis

The key exposure is not simply delayed US capex: it is whether SK hynix can convert a policy-dependent China cash-generation plan into a credible US investment commitment. If licenses remain blocked, the New York project becomes less financeable on the stated rationale and Solidigm’s location choice may remain optional rather than incremental capacity. That weakens the value investors should assign to the proposed buildout today. If Washington ultimately grants an exception, it could establish a template for other foreign memory makers to seek comparable treatment, diluting the practical force of controls; a denial instead raises the risk premium on SK hynix’s China-linked production and future cross-border projects.

Near term, the unresolved decision is likely more important than the headline investment figure: no specific US fab decision is confirmed, and no direct earnings impact can be sized from the information available. Over 1–3 months, watch for a license decision, White House involvement, and any change in Solidigm’s site or funding language. Over 6–18 months, sustained restrictions could constrain SK hynix’s ability to upgrade Dalian while delaying potential US capacity. Samsung Electronics, Micron, and Kioxia could gain relative negotiating leverage or benefit if NAND supply growth is deferred, but that depends on actual capacity plans and demand; it is not an automatic pricing tailwind.

Contrarian angle: markets may over-credit the proposed US investment as certain while underpricing the possibility that China restrictions make it uneconomic. Conversely, an eventual license could relieve the immediate overhang without making the US project binding. Falsifiers include a formal license denial or approval, a confirmed Solidigm site/capex decision, and SK hynix guidance that quantifies any production or investment change.

Key Decisions for Investors

• Do not trade the proposed US fab as committed capacity. Keep SKHY on a policy-event watchlist; verify license scope, timing, and whether the separate 2027 sustaining-equipment request is affected.
• Consider a conditional relative-value hedge—long a diversified memory peer basket including Micron and Samsung Electronics versus short SKHY—only if restrictions are formally tightened and SKHY’s guidance confirms material production or capex consequences. The thesis fails if licenses are approved without meaningful conditions or peers announce offsetting capacity additions.
• Avoid extrapolating a NAND price benefit from delayed Dalian expansion until actual capacity and inventory data show a supply response; check NAND contract pricing, utilization, and peer capex before adding exposure.
• Treat Solidigm’s New York plan as an option, not a catalyst, until a specific site, funding path, and construction schedule are confirmed. Reassess if the company formalizes the project or withdraws it.